cafepharmaBrand managers reflect on historic launch of Wegovy—Jardiance doesn’t cut it in post-heart attack trial—FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers--http://bit.ly/w28kSd #druglaunch #novonordisk #wegovy #brandmanagers #jardiance #clinicaltrials #heartattack #her2positive #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
